Back to Global NewsPublished: 23 Feb 2026Download AppJoin TelegramWhy Syndax's Roadshow May Spark a Cancer-Drug Rally: What Investors Need to Know#Syndax#Cancer therapeutics#Biopharma#Investor conference#Menin inhibitor#CSF-1 antibody#Portfolio strategyDownload AppJoin CommunityShare Article